Cart
sales@molnova.com
Dicycloplatin
CAS No. 287402-09-9
Dicycloplatin ( —— )
Catalog No. M13878 CAS No. 287402-09-9
Dicycloplatin (DCP) is a novel platinum analog that demonstrates significant antitumor activity against a variety of human cancer cell lines with IC50 of 25-30 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDicycloplatin
-
NoteResearch use only, not for human use.
-
Brief DescriptionDicycloplatin (DCP) is a novel platinum analog that demonstrates significant antitumor activity against a variety of human cancer cell lines with IC50 of 25-30 nM.
-
DescriptionDicycloplatin (DCP) is a novel platinum analog that demonstrates significant antitumor activity against a variety of human cancer cell lines with IC50 of 25-30 nM; has better solubility and stability than both cisplatin and carboplatin.Chemotherapeutic Agents Phase 2 Clinical
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetDNA Alkylator
-
RecptorDNA Alkylator
-
Research AreaCancer
-
IndicationChemotherapeutic
Chemical Information
-
CAS Number287402-09-9
-
Formula Weight515.38
-
Molecular FormulaC12H20N2O8Pt
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC1CC(C1)(C(=O)O)C(=O)O.C1CC(C1)(C(=O)[O-])C(=O)[O-].N.N.[Pt+2]
-
Chemical NamePlatinum(2+) 1-carboxycyclobutanecarboxylate ammoniate (1:2:2)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yu JJ, et al. Anticancer Res. 2014 Jan;34(1):455-63.
2. Li GQ, et al. PLoS One. 2012;7(11):e48994.
3. Liu KJ, et al. Arch Med Sci. 2014 Aug 29;10(4):717-24.
2. Li GQ, et al. PLoS One. 2012;7(11):e48994.
3. Liu KJ, et al. Arch Med Sci. 2014 Aug 29;10(4):717-24.
molnova catalog
related products
-
CM03
CM03 is a G-quadruplex-binding compound that potently inhibits cell growth in PDAC cell lines (MIA PaCa-2 IC50=19 nM).
-
Bisantrene
A small molecule DNA intercalater with antineoplastic activity, does not exhibit cardiotoxicity compared with doxorubicin; induces both protein-associated DNA single-strand breaks and DNA-protein crosslinks in cancer cells.
-
KCC-07
KCC-07 is a selective, potent and brain-penetrant inhibitor of methyl-CpG-binding domain protein 2(MBD2) with anticancer activity.
